-+ 0.00%
-+ 0.00%
-+ 0.00%

ProKidney Q1 EPS $(0.13) Beats $(0.16) Estimate, Sales $230.00K

Benzinga·05/12/2025 20:17:47
Listen to the news
ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.16) by 18.75 percent. This is a 18.75 percent increase over losses of $(0.16) per share from the same period last year. The company reported $230.00 thousand in sales this quarter.